Dr. David Stahl will work on his Project “Inducing MHC Class I expression in soft tissue sarcomas to restore anti-tumor immunity and increase the efficacy of immune checkpoint blockade" in the lab of Prof. Dr. Roland Ullrich
The training concept for our fellows is based on three major pillars: scientific qualification, technical expertise and professionalism.
Our fellows will receive thorough scientific training both within their chosen research groups and our program that we have established and further improved during the first funding period of the EKF.
Regular supervisions will enable our fellows to present their data and knowledge to respective leaders of the field and engage in stimulating scientific exchange.
We are convinced that our support and mentoring structures provide effective chaperonagefor our fellows.
Our consortium has been successful in promoting the independent careers of our fellows participating in the first funding period.
We have implemented numerous intramural funding mechanisms that will ensure the continued scientific success of our fellows following completion of the initial laboratory rotation.
The career development of these fellows serves as a blueprint, and we expect to see additional fellows to move into independence during the second funding period.
We are very much looking forward seeing our new fellow David Stahl grow as a Clinican Scientist.